Stefan Gräf Selected Research

Connective Tissue Diseases (Connective Tissue Disease)

10/2021

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Gräf Research Topics

Disease

14	Pulmonary Arterial Hypertension 03/2024 - 07/2015
2	Inflammation (Inflammations) 03/2024 - 01/2019
2	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2023 - 11/2017
2	Pulmonary Hypertension 11/2023 - 01/2019
2	COVID-19 01/2023 - 10/2021
2	Rare Diseases (Rare Disease) 12/2022 - 11/2017
2	Familial Primary Pulmonary Hypertension 10/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 05/2013 - 10/2012
1	Starvation 03/2024
1	Vascular Remodeling 11/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Vascular System Injuries 01/2023
1	Body Weight (Weight, Body) 07/2022
1	Right Ventricular Dysfunction 10/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2021
1	Congenital Heart Defects (Congenital Heart Defect) 10/2021
1	Disease Progression 10/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021
1	Stroke (Strokes) 01/2021
1	Dementia (Dementias) 01/2021
1	CADASIL 01/2021
1	Disease Susceptibility (Diathesis) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Pulmonary Embolism 01/2019
1	Channelopathies 10/2018
1	Lymphadenopathy 11/2017
1	Hypoxia (Hypoxemia) 07/2015
1	Neoplasms (Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

4	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2023 - 07/2015
3	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 11/2020 - 07/2015
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	ProteomeIBA 01/2022 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 10/2021
2	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2020
2	Carbon MonoxideIBA 01/2020 - 11/2017
1	Serine (L-Serine)FDA Link 03/2024
1	Activating Transcription Factor 4IBA 03/2024
1	Betaine (C.B.B.)FDA Link 03/2024
1	XenobioticsIBA 03/2024
1	Proline (L-Proline)FDA Link 03/2024
1	Cathepsin ZIBA 01/2024
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 11/2023
1	Protein Kinases (Protein Kinase)IBA 11/2023
1	cadherin 5IBA 11/2023
1	CalpainIBA 01/2023
1	Transcription Factor 4IBA 12/2022
1	Estrogens (Estrogen)FDA Link 07/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 10/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	CytokinesIBA 10/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2021
1	ElafinIBA 10/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	hemoglobin DIBA 01/2020
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	N 30IBA 01/2019
1	AntigensIBA 01/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	PotassiumIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	Prokaryotic Initiation Factor-2IBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2015
1	MonocrotalineIBA 07/2015
1	MicroRNAs (MicroRNA)IBA 05/2013
1	Estrogen ReceptorsIBA 10/2012
1	Hematoxylin (Haematoxylon)IBA 10/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2012

Therapy/Procedure

3	Therapeutics 03/2024 - 01/2023
1	Endarterectomy (Thromboendarterectomy) 01/2019